Leukaemia is a type of cancer that affects immature blood cells in the body. It is a very serious and potentially life-threatening form of cancer, and therefore early diagnosis is essential for successful treatment. Though there are no currently approved home-diagnosis methods for leukaemia, there are steps individuals can take to recognize signs and symptoms and seek appropriate medical treatment.
The first symptom that may alert individuals to seek medical attention for suspicion of leukaemia is often an enlarged spleen or swollen lymph nodes. Swollen lymph nodes, particularly on the sides of the neck and armpits, can be a sign of the onset of leukaemia. It is also important to note other changes in the body such as persistent fatigue, frequent fevers and night sweats, bleeding or bruising easily, and petechiae – small red or purple spots that appear on the skin from broken capillaries.
When these concerns arise, the next step is to discuss them with a physician. The doctor may opt for a physical examination and lab tests, such as a complete blood count (CBC) to measure levels of red blood cells, white blood cells, platelets, haemoglobin and hematocrit. A CBC can also help detect blood cell abnormalities, further indicating the presence of cancer.
Additional screenings can help confirm a leukaemia diagnosis if it is considered likely. Bone marrow aspirates and biopsies can be taken to analyze the structure and the cells in the marrow, helping to identify if cancerous cells are present. A CT scan of the chest, abdomen and pelvis can also be used to determine if there is an enlarged spleen or enlarged lymph nodes.
Finally, a blood test can be undertaken to look for changes in chromosomes and proteins that are unique to the leukaemia. By testing for specific markers, a physician can be more certain of the presence of cancer and make a definitive diagnosis.
Dasatinib (50mg) is a prescription medication used for multiple types of cancer, including chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ALL). It works by targeting proteins in the body that contribute to the rapid proliferation of cancer cells, thus preventing the growth and spread of cancer.
Dasatinib (50mg) is an oral, small-molecule tyrosine kinase inhibitor and works as an anti-cancer drug by blocking several proteins in cancer cells from stimulating the proliferation of cancer cells. Specifically, Dasatinib (50mg) use is to target certain proteins (Bcr-Abl, SrcPTP and PDGFR-α) in cancer cells that are responsible for causing CML, Ph+ ALL and other forms of leukaemia. By blocking these proteins, Dasatinib (50mg) effectively prevents the growth and spread of cancer.
Dasatinib (50mg) use is prescribed in combination with chemotherapy drugs depending on the type of cancer, the severity of the condition and the patient's health history. It is usually taken orally once a day, usually with or without food. The amount of Dasatinib (50mg) that may be prescribed depends on factors such as an individual’s age, weight, other medical conditions, and the severity of cancer.
Dasatinib 50mg tablet is an important medication in the treatment of various forms of cancer, including CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ALL). By blocking the proteins responsible for causing cancer cells to proliferate, Dasatinib (50mg) prevents the growth and spread of cancer. The side effects of taking this medication may include fatigue, hair loss, nausea, and vomiting, diarrhoea, low blood pressure, risk of blood clot formation, and swelling. It is important to always discuss with a medical practitioner before taking any medications in conjunction with Dasatinib (50mg) so that all potential risks can be taken into account.
At this time, there is no way for individuals to accurately diagnose leukaemia from home. The only way to be certain is to speak to a physician, undergo tests and screenings and consider the results to determine if cancer is present. Recognizing warning signs, such as swelling and lumps in the neck and armpits, fatigue and petechiae, can be the first step in confirming that cancer is present and in seeking appropriate medical treatment and care.
